tiprankstipranks
Geratherm Medical AG (GB:0EL9)
LSE:0EL9

Geratherm Medical (0EL9) Share Price & Analysis

0 Followers

0EL9 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€7.34 - €7.34
Previous Close€7.34
Volume0.00
Average Volume (3M)N/A
Market Cap
€23.41M
Enterprise Value€23.16M
Total Cash (Recent Filing)€10.50M
Total Debt (Recent Filing)€10.48M
Price to Earnings (P/E)N/A
BetaN/A
Apr 25, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.13
R-Squared0.00285
Alpha-0.00426
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

0EL9 FAQ

What was Geratherm Medical AG’s price range in the past 12 months?
Geratherm Medical AG lowest share price was €7.34 and its highest was €7.34 in the past 12 months.
    What is Geratherm Medical AG’s market cap?
    Currently, no data Available
    When is Geratherm Medical AG’s upcoming earnings report date?
    Geratherm Medical AG’s upcoming earnings report date is Apr 25, 2024 which is yesterday.
      How were Geratherm Medical AG’s earnings last quarter?
      Geratherm Medical AG released its earnings results on Nov 23, 2023. The company reported €0.13 earnings per share for the quarter, beating the consensus estimate of N/A by €0.13.
        Is Geratherm Medical AG overvalued?
        According to Wall Street analysts Geratherm Medical AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Geratherm Medical AG pay dividends?
          Geratherm Medical AG does not currently pay dividends.
          What is Geratherm Medical AG’s EPS estimate?
          Geratherm Medical AG’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Geratherm Medical AG have?
          Geratherm Medical AG has 5,444,998 shares outstanding.
            What happened to Geratherm Medical AG’s price movement after its last earnings report?
            Geratherm Medical AG reported an EPS of €0.13 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Geratherm Medical AG?
              Currently, no hedge funds are holding shares in GB:0EL9
              ---

              Geratherm Medical Stock Smart Score

              Company Description

              Geratherm Medical AG

              Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Genedrive
              EKF Diagnostics Holdings
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis